During the remaining duration of medication beyond the first month, there is little noticeable difference in the occurrence probability of adverse events between the two administration routes
Useful research measures may include waist circumference, appetite, cravings, portion sizes, eating behavior, energy, physical activity, body composition, metabolic markers, hydration, and side effects
GI Side Effects and Dehydration: Nausea, vomiting, and diarrhea are common side effects across all GLP-1 and GIP/GLP-1 agonists
Patients with type 2 diabetes have an approximately two-fold risk for acute pancreatitis and a label indicating an acute pancreatitis risk has been added to all DPP-4 inhibitors
Using pharmacological agents with cardiovascular and renal benefits, including renin-angiotensin system inhibitors and sodium-glucose cotransporter-2 inhibitors, is paramount
Harshbarger, W